Search - tctmd.com

Displaying 301 - 320 of 365

Sort: Relevancy | Date

Effect of Ticagrelor on the Outcomes of Patients With Prior Coronary Artery Bypass Graft Surgery: Insights From The PLATelet inhibition and patient Outcomes (PLATO) trial

Presentation TCT 2013

Effect of Ticagrelor on the Outcomes of Patients With Prior Coronary Artery Bypass Graft Surgery: Insights From The PLATelet inhibition and patient Outcomes (PLATO) trial

Presenter: Emmanouil Brilakis, Claes Held, Bernhard Meier, Frank Cools, Marc Claeys, Jan Cornel, Philip Aylward, Basil Lewis, Douglas Weaver, Gunnar Brandrup- Wognsen, Susanna Stevens, Lars Wallentin, Stefan James

January 31, 2013

Double (360mg) Loading Dose Of Ticagrelor In Patients With ST-elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention

Presentation TCT 2013

Double (360mg) Loading Dose Of Ticagrelor In Patients With ST-elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention

Presenter: Dimitrios Alexopoulos, Ioanna Xanthopoulou, Vassilios Gkizas, George Kassimis, Konstantinos Theodoropoulos, Tsigkas Grigorios, Ioannis Chiladakis, Anastasia Damelou, George Hahalis, Periklis Davlouros

January 31, 2013

News Daily News

La Adenosina podría ser el Nexo de Unión entre el Ticagrelor y la Disnea

January 09, 2013

News Daily News

Adenosine May Be the Tie That Binds Ticagrelor and Dyspnea

January 09, 2013

Ticagrelor Enhances Adenosine-Induced Coronary Vasodilatory Responses in Humans

Presentation

Ticagrelor Enhances Adenosine-Induced Coronary Vasodilatory Responses in Humans

Presenter: A. Wittfeldt

January 08, 2013

News Daily News

Subestudio PLATO: La Ventaja del Ticagrelor Persiste tras el 1er Episodio Isquémico

January 07, 2013

News Daily News

PLATO Substudy: Ticagrelor Advantage Persists After First Ischemic Event

January 07, 2013

Reduction in First and Recurrent Cardiovascular Events with Ticagrelor vs. Clopidogrel

Presentation

Reduction in First and Recurrent Cardiovascular Events with Ticagrelor vs. Clopidogrel

Presenter: P. Kohli

January 06, 2013

News Daily News

Una Dosis Alta de Aspirina tras una PCI Primaria aumenta las Hemorragias No observandose Beneficio Isquémico alguno

December 19, 2012

News Daily News

High-Dose Aspirin After Primary PCI Increases Bleeding with No Ischemic Benefit

December 19, 2012

News Daily News

Risk Peaks Early After Clopidogrel Cessation in SVG PCI Patients

November 13, 2012

Ticagrelor Update: PLATO: Recent Analyses

Presentation TCT 2012

Ticagrelor Update: PLATO: Recent Analyses

Presenter: Robert Harrington

October 24, 2012

Ticagrelor Is the Right Choice: More Potent, Better Data!

Presentation TCT 2012

Ticagrelor Is the Right Choice: More Potent, Better Data!

Presenter: Dimitrios Alexopoulos

October 24, 2012

News Daily News

Subestudio PLATO: El Ticagrelor se asocia a Menos Hemorragias, Infecciones y Muerte que el Clopidogrel tras CABG

September 27, 2012

News Daily News

PLATO Substudy: Ticagrelor Associated with Less Bleeding, Infection, Death than Clopidogrel after CABG

September 27, 2012

Factors Contributing to Lower Mortality with Ticagrelor Compared with Clopidogrel in Patients Undergoing CABG Surgery

Presentation

Factors Contributing to Lower Mortality with Ticagrelor Compared with Clopidogrel in Patients Undergoing CABG Surgery

Presenter: Christoph Varenhorst

September 26, 2012

News Daily News

La Dosis de Carga Doble de Clopidogrel No Ofrece Beneficio Alguno en Pacientes con ERC que se someten a PCI Primarias

September 18, 2012

News Daily News

Double Clopidogrel Loading Dose Offers No Benefit in Primary PCI Patients with CKD

September 18, 2012

News Conference News ESC 2012

Prolonged Vorapaxar Enhances Secondary Prevention in Selected Post-MI Patients

August 26, 2012

News Conference News ESC 2012

Comparable Long-Term Safety, Efficacy with Prasugrel, Clopidogrel in ACS

August 26, 2012

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.